Efficacy and Safety of Accelerated Intermittent Theta-burst Stimulation (a-iTBS) in Adolescents With Depressive Disorder

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age12-18
SponsorFirst Affiliated Hospital of Chongqing Medical University

About this trial

This study aims to assess the feasibility, safety, acceptability, and preliminary efficacy trends of a Accelerated Intermittent Theta-burst Stimulation (a-iTBS) intervention for adolescent depression through a pilot clinical trial. The findings will inform the design and optimization of subsequent formal randomized controlled trials, providing essential evidence for their execution.

Eligibility criteria

Qualifiers

None

Disqualifiers

Psychiatric comorbidities other than anxiety disorders

Depression with psychotic symptoms

Young Mania Rating Scale (YMRS) score >13

A history of neurological disorders (e.g., epilepsy, brain injury) or severe somatic diseases (e.g., thyroid disorders, lupus, diabetes, pulmonary, hepatic, or renal impairment, major trauma)

Trial design

Treatments tested in this trial

  • Experimental target a-iTBS treatment
  • Conventional target a-iTBS treatment
  • Sham stimulation treatment

Treatment groups

45 Participants
are divided into 3 treatment groups